Here, we found much higher levels of TRAIL R1 in the 8 patients with diabetes compared to non-diabetic patients, indicating that TRAIL R1 might contribute to diabetes-related COVID-19 disease severity. Here, TNFRSF10A is linked to diabetes mellitus.